NVAX Financial Facts
General and administrative: 13.56MNet loss: -66.25M
See Full Income Statement
Accounts payable: 16.23M
Accounts receivables: 591K
See Full Balance Sheet
Novavax, Inc. (NVAX) Earnings
|
Expand Research on NVAX
| Next EPS Date | 8/6/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +513.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +8.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/26  |
Q126 | N/A | -$0.24 | N/A | N/A | $77.95M | N/A | N/A | N/A | ||
| 2/26/26 |
Q425 | $0.11 | -$0.49 | +$0.60 | $147M | $90.25M | N/A |  | | Details | |
| 11/6/25 |
Q325 | N/A | -$0.54 | N/A | N/A | $55.66M | = | N/A | N/A | ||
| 8/6/25 | Q225 | $0.62 | -$0.06 | +$0.68 | $239M | $156.23M | = | | | Details | |
| 5/8/25 |
Q125 | $2.93 | -$0.43 | +$3.36 | $667M | $251.8M | = | | | Details | |
| 2/27/25 | Q424 | -$0.51 | -$0.60 | +$0.09 | $88.31M | $102.74M | = | | | Details | |
| 11/12/24 | Q324 | -$0.76 | -$0.83 | +$0.07 | $85M | $65.8M | = | | | Details | |
| 8/8/24 |
Q224 | N/A | $1.67 | N/A | N/A | $464.83M | = | N/A | N/A |
